Transient osteoporosis of pregnancy (TOP) is a rare and often misdiagnosed disease during pregnancy. The postpartum fatigue or stress fracture is a recognized cause of pain, the diagnosis of postpartum osteoporosis (PPO) should be considered in the differential diagnosis of disabling lumbalgia occurring either during pregnancy (especially in the third trimester) or immediately after delivery. We report here the case of a 31-year-old patient, primiparous with no particular history, who presented disabling radiating pubic pain on the fourth day of postpartum after her caesarean section, that pelvic MRI had shown a fracture of the left sacral fin, associated with osteopenia of the hip. Her phosphocalcic assessment had objectified a vitamin D deficiency.

Introduction: Recurrent disease is a genetic autoinflammatory disease autosomal recessive with particular ethnic distribution. Chronic disease evolution paroxysmal often beginning at childhood and characterized by inflammation of the serous with the main risk amyloidosis. Colchicine is the standard treatment. The management of the carrier pregnant women with this disease should be done in collaboration between internist, obstetrician and nephrologist in patients with renal impairment.
Observation: We report the case of a woman in labor to 41 years, G5P2 mother of two children with a history of two spontaneous abortions, for MFM Followed by colchicine stopped since the desire to design with pregnancy marked by the occurrence of one crisis first trimester of pregnancy. The evolution was unremarkable and vaginal delivery of a newborn male eutrophic 10/10 Apgar.
Discussion and conclusion: FMF Treaty and colchicine have no major impact on the reproductive life of women of childbearing age subject to proper monitoring and good compliance. Obstetrical prognosis is especially marked by the increased risk of abortion in cases of early pregnancy crisis.

Neuroendocrine tumors with small cell cervical represent less than 2% of cervical cancers, and if their evolution depends on the volume and tumor stage, prognosis is generally dark Morphological characteristics and clinical features of these tumors are comparable with neuroendocrine tumors of the lung. This tumor can also be found in other sites such as the skin, gastrointestinal tract, pancreas and cervical region.
We report two new cases of neuroendocrine carcinoma of the cervix small cell and through the literature data we review the different aspects of this rare entity.